Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000812286 | SCV000952595 | uncertain significance | Renal carnitine transport defect | 2021-08-26 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with valine at codon 9 of the SLC22A5 protein (p.Ala9Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs753998904, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Giacomini Lab, |
RCV000812286 | SCV002576693 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Natera, |
RCV002226496 | SCV002075429 | uncertain significance | Decreased circulating carnitine concentration | 2020-12-30 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000812286 | SCV002107404 | uncertain significance | Renal carnitine transport defect | 2020-12-30 | no assertion criteria provided | clinical testing |